TY  - GEN
AU  - Kato,Koji
AU  - Yoshida,Nao
AU  - Matsumoto,Kimikazu
AU  - Matsuyama,Takaharu
TI  - Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia
SN  - 1545-5017
PY  - 2014///0408
KW  - Adolescent
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Marrow Transplantation
KW  - Busulfan
KW  - administration & dosage
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Cytarabine
KW  - Female
KW  - Follow-Up Studies
KW  - Graft vs Host Disease
KW  - mortality
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Melphalan
KW  - Neoplasm Recurrence, Local
KW  - Postoperative Complications
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prognosis
KW  - Remission Induction
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - Whole-Body Irradiation
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/pbc.24922
ER  -